loader from loading.io

Hospital Drug Diversion Detection and Prevention with Russ Nix and Dr. Stacey McCoy Wolters Kluwer Health

Empowered Patient Podcast

Release Date: 03/23/2026

AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI TRANSCRIPT show art AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI TRANSCRIPT

Empowered Patient Podcast

Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform where individuals can build their complete health story, integrating modern and functional medicine with a more holistic approach, which AI analyzes to help doctors connect disparate symptoms, ask the right questions, identify patterns, and reach the correct diagnosis faster while reducing...

info_outline
AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI show art AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI

Empowered Patient Podcast

Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform where individuals can build their complete health story, integrating modern and functional medicine with a more holistic approach, which AI analyzes to help doctors connect disparate symptoms, ask the right questions, identify patterns, and reach the correct diagnosis faster while reducing...

info_outline
How EHR Systems Use Clinical AI to Advance Interoperability  with Ben Scharfe Altera Digital Health TRANSCRIPT show art How EHR Systems Use Clinical AI to Advance Interoperability with Ben Scharfe Altera Digital Health TRANSCRIPT

Empowered Patient Podcast

Ben Scharfe, Executive VP of AI at Altera Digital Health, addresses the evolving regulatory landscape for AI in healthcare, emphasizing AI developers' primary responsibility to ensure transparency so clinicians can understand and verify AI-generated outputs. AI is positioned to be a supportive tool for providers, not as an autonomous decision-maker, with emerging regulations beginning to codify the human-in-the-loop requirement. Ben warns of setting higher standards for AI than physicians and automation complacency, in which clinicians might over-rely on AI. Ben explains, "Altera provides...

info_outline
How EHR Systems Use Clinical AI to Advance Interoperability  with Ben Scharfe Altera Digital Health show art How EHR Systems Use Clinical AI to Advance Interoperability with Ben Scharfe Altera Digital Health

Empowered Patient Podcast

Ben Scharfe, Executive VP of AI at Altera Digital Health, addresses the evolving regulatory landscape for AI in healthcare, emphasizing AI developers' primary responsibility to ensure transparency so clinicians can understand and verify AI-generated outputs. AI is positioned to be a supportive tool for providers, not as an autonomous decision-maker, with emerging regulations beginning to codify the human-in-the-loop requirement. Ben warns of setting higher standards for AI than physicians and automation complacency, in which clinicians might over-rely on AI. Ben explains, "Altera provides...

info_outline
Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians TRANSCRIPT show art Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians TRANSCRIPT

Empowered Patient Podcast

Dr. John Birkmeyer, President of the medical group at Sound Physicians, defines value-based care as an evolution from older managed care models, with closer alignment of incentives for quality of care and cost-effectiveness. Working within the hospital environment, this approach emphasizes standardizing patient-centered care and communication across multiple hospital departments, reducing redundant tests and improving patient outcomes. The use of AI is one way to reduce the administrative burden on physicians, freeing up more time for patient care, a departure from earlier technologies that...

info_outline
Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians show art Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians

Empowered Patient Podcast

Dr. John Birkmeyer, President of the medical group at Sound Physicians, defines value-based care as an evolution from older managed care models, with closer alignment of incentives for quality of care and cost-effectiveness. Working within the hospital environment, this approach emphasizes standardizing patient-centered care and communication across multiple hospital departments, reducing redundant tests and improving patient outcomes. The use of AI is one way to reduce the administrative burden on physicians, freeing up more time for patient care, a departure from earlier technologies that...

info_outline
Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research TRANSCRIPT show art Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research TRANSCRIPT

Empowered Patient Podcast

Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the Berenson Cancer Center, describes the Institute's work, which includes maintaining a large biobank of patient samples that support both its own research and that being conducted by external groups. This biobank is being used to develop new blood markers for faster disease diagnosis, to assess treatment efficacy, and to support drug development for multiple myeloma and other cancers. Real-time monitoring of patient symptoms with a mobile app is capturing critical, often-missed patient data and providing...

info_outline
Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research show art Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research

Empowered Patient Podcast

Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the Berenson Cancer Center, describes the Institute's work, which includes maintaining a large biobank of patient samples that support both its own research and that being conducted by external groups. This biobank is being used to develop new blood markers for faster disease diagnosis, to assess treatment efficacy, and to support drug development for multiple myeloma and other cancers. Real-time monitoring of patient symptoms with a mobile app is capturing critical, often-missed patient data and providing...

info_outline
Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi TRANSCRIPT show art Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi TRANSCRIPT

Empowered Patient Podcast

Tom Looby, CEO of Conavi, is focused on developing hybrid intravascular imaging technology that combines two established modalities into a single imaging catheter to provide a comprehensive view of the coronary arteries. This eliminates blind spots when using either intravascular ultrasound (IVUS) or optical coherence tomography (OCT) alone and is driving a shift away from relying solely on traditional angiography toward the use of advanced intravascular imaging to guide coronary procedures. Using AI to analyze dual-stream co-registered data allows interventional cardiologists to more...

info_outline
Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi show art Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi

Empowered Patient Podcast

Tom Looby, CEO of Conavi, is focused on developing hybrid intravascular imaging technology that combines two established modalities into a single imaging catheter to provide a comprehensive view of the coronary arteries. This eliminates blind spots when using either intravascular ultrasound (IVUS) or optical coherence tomography (OCT) alone and is driving a shift away from relying solely on traditional angiography toward the use of advanced intravascular imaging to guide coronary procedures. Using AI to analyze dual-stream co-registered data allows interventional cardiologists to more...

info_outline
 
More Episodes

Russ Nix, Consulting Associate Director, and Dr. Stacey McCoy, Pharmacy Clinical Program Manager for the Clinical Surveillance and Compliance business at Wolters Kluwer Health, highlight the problem of drug diversion in healthcare environments and the shared responsibility to prevent this breach. AI-enabled software is becoming crucial in detecting suspicious patterns, the types of individuals most likely to steal drugs, and gaps in the supply chain from ordering to delivering drugs to the patient. While opioids are the most commonly diverted drugs, motivated by substance abuse and addiction, other medications, including non-controlled substances, insulin, and high-cost cancer drugs, are also at risk. Effective prevention programs focus on a culture in which staff feel safe reporting concerns and seeking help.

Russ explains, "Drug diversion is basically when you're in a healthcare system where the medications in that facility are not going to their intended destination. And that's typically what we see most of, a deliberate taking of those medications, whether it was a substance abuse issue or your healthcare practitioners or staff outside of the facility, are taking those medications and basically denying your patients that medication. And it is a pretty significant issue since the opioid crisis, again in the early 2000s or late 1990s."  

Stacey elaborates, "So ideally, we want to be in a position where we're able to utilize software applications or a mixture of software applications to have oversight of what's being ordered, what's coming in, and what's going on inside our pharmacies, what's inside the machines on each hospital floor. Just imagine you have such a varied audience. Every single hospital floor has 15 or so nurses working. Those nurses need to grab medications from machines, like a vending machine. So the pharmacist is responsible for making sure that's taking place properly."

"Then that same team or person was also responsible for making sure that what's removed from the machines truly makes it to the patients in a safe and sound manner. So there are a number of breakpoints within the process that someone has to oversee. Ideally, we'd like to make sure that drug diversion prevention takes place using the most up-to-date software applications that are AI-enabled, and that we have multidisciplinary governance on these teams."

#WoltersKluwerHealh #AISurveillance #DrugDiversionPrevention #Sentri7DrugDiverison #PatientSafety #DrugDiversion #HealthcareSecurity #OpioidCrisis #PharmacySafety #HealthcareCompliance #PatientCare #MedicationSafety #HealthcareLeadership #AIinHealthcare

wolterskluwer.com

Download the transcript here

Wolters